$AKTS
Price history, market instrument context, member research, and related headlines in one place.
AKTS key statistics
NasdaqGSUSD
52-week range
$14.727%$34.19
Latest session $15.77–$17.08Aktis Oncology, Inc. (AKTS) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $16.01, down $0.48 (2.91%) from the previous close of $16.49. It has traded between $15.77 and $17.08 in the latest session. Over the past year it has ranged from $14.72 to $34.19, leaving it in the lower quarter of its 52-week range (7%). Reported volume for the session was 667.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Wedbush initiates Aktis Oncology stock with outperform rating — See source for full details.
Loading $AKTS research…